[Challenges for psychotropics in the context of the SARS-Cov-2 pandemic].
Enjeux de l’utilisation des psychotropes dans le cadre de la pandémie au SARS-Cov-2.
Anti-Anxiety Agents
/ adverse effects
Antiviral Agents
/ adverse effects
Betacoronavirus
/ drug effects
COVID-19
Comorbidity
Coronavirus Infections
/ drug therapy
Drug Repositioning
Dyspnea
/ chemically induced
Humans
Hypnotics and Sedatives
/ adverse effects
Mental Disorders
/ drug therapy
Pandemics
Pneumonia, Viral
/ drug therapy
Psychotropic Drugs
/ adverse effects
Respiration
/ drug effects
Risk Assessment
SARS-CoV-2
COVID-19 Drug Treatment
COVID-19
Psychotropes
Psychotropics
Recommandations
Recommendations
SARS-Cov-2
Journal
L'Encephale
ISSN: 0013-7006
Titre abrégé: Encephale
Pays: France
ID NLM: 7505643
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
17
04
2020
accepted:
20
04
2020
pubmed:
4
5
2020
medline:
14
7
2020
entrez:
4
5
2020
Statut:
ppublish
Résumé
French recommendations have been proposed for psychotropics use and possible adaptations during the SARS-CoV-2 epidemic. Between uncertainties linked to the lack of data and speculations about possible benefits of psychotropics against the coronavirus, we propose here elements allowing to base the pharmacotherapeutic decisions potentially useful in Covid+ patients with psychiatric disorders.
Identifiants
pubmed: 32360037
pii: S0013-7006(20)30077-4
doi: 10.1016/j.encep.2020.04.009
pmc: PMC7177137
pii:
doi:
Substances chimiques
Anti-Anxiety Agents
0
Antiviral Agents
0
Hypnotics and Sedatives
0
Psychotropic Drugs
0
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
S116-S118Informations de copyright
Copyright © 2020 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.
Références
Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93
pubmed: 24841273
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Encephale. 2020 Jun;46(3S):S14-S34
pubmed: 32376004
Cochrane Database Syst Rev. 2013 May 31;(5):CD003002
pubmed: 23728641
Drugs. 2017 Dec;77(18):1935-1966
pubmed: 29143192
J Psychopharmacol. 2018 Nov;32(11):1167-1181
pubmed: 30334664
Arch Virol. 2015 Apr;160(4):1015-20
pubmed: 25663217
Cochrane Database Syst Rev. 2016 Oct 20;10:CD007354
pubmed: 27764523
Cell Discov. 2020 Mar 16;6:14
pubmed: 32194980
J Clin Psychiatry. 2013 Jan;74(1):e79-86
pubmed: 23419234
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
J ECT. 2020 Jun;36(2):86-87
pubmed: 32433120
Expert Rev Respir Med. 2019 Feb;13(2):173-180
pubmed: 30596298
J Virol. 2005 Jun;79(11):7095-103
pubmed: 15890949
PLoS One. 2018 Mar 22;13(3):e0194868
pubmed: 29566060
J Psychiatry Neurosci. 2020 Apr 03;45(3):222-223
pubmed: 32297722
World Psychiatry. 2020 Feb;19(1):120-121
pubmed: 31922665
Palliat Med. 2018 Oct;32(9):1518-1521
pubmed: 30028237
Encephale. 2020 Jun;46(3S):S3-S13
pubmed: 32312567